Shoko Vos

Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.

B Coiffier, E.A. Osmanov, Xin Hong et al. · The Lancet Oncology · 2011 · 1.6K citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +5

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Shoko Vos, Cathy B. Moelans, Paul Joannes van Diest · Breast Cancer Research · 2017 · 48 citations · Full text

Integrating artificial intelligence in pathology: a qualitative interview study of users' experiences and expectations

Jojanneke Drogt, Megan Milota, Shoko Vos et al. · Modern Pathology · 2022 · 47 citations · Full text

Multi-modal tissue sampling in cone beam CT guided navigation bronchoscopy: comparative accuracy of different sampling tools and rapid on-site evaluation of cytopathology

Roel L.J. Verhoeven, Shoko Vos, Erik H.F.M. van der Heijden · Journal of Thoracic Disease · 2021 · 32 citations · Full text

miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers

Shoko Vos, Farhad Vesuna, Venu Raman et al. · Oncotarget · 2015 · 29 citations · Full text